These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 17214846)

  • 21. Can systemic diseases co-induce (not just exacerbate) periodontitis? A hypothetical "two-hit" model.
    Golub LM; Payne JB; Reinhardt RA; Nieman G
    J Dent Res; 2006 Feb; 85(2):102-5. PubMed ID: 16434727
    [No Abstract]   [Full Text] [Related]  

  • 22. Perspective of cytokine regulation for periodontal treatment: fibroblast biology.
    Takashiba S; Naruishi K; Murayama Y
    J Periodontol; 2003 Jan; 74(1):103-10. PubMed ID: 12593604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rheumatoid arthritis and periodontitis: biological links and the emergence of dual purpose therapies.
    Modi DK; Chopra VS; Bhau U
    Indian J Dent Res; 2009; 20(1):86-90. PubMed ID: 19336867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of TNF-α-mediated inflammatory responses by a benzodioxolylacetylamino-linked benzothiazole analog in human fibroblast-like synoviocytes.
    Lee YR; Jin GH; Lee SM; Park JW; Ryu JH; Jeon R; Park BH
    Biochem Biophys Res Commun; 2011 May; 408(4):625-9. PubMed ID: 21530496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. META060 attenuates TNF-α-activated inflammation, endothelial-monocyte interactions, and matrix metalloproteinase-9 expression, and inhibits NF-κB and AP-1 in THP-1 monocytes.
    Desai A; Darland G; Bland JS; Tripp ML; Konda VR
    Atherosclerosis; 2012 Jul; 223(1):130-6. PubMed ID: 22658256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The design and implementation of trials of host modulation agents.
    Offenbacher S; Salvi GE; Beck JD; Williams RC
    Ann Periodontol; 1997 Mar; 2(1):199-212. PubMed ID: 9151554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of periodontitis: role of cytokines in host response.
    Deo V; Bhongade ML
    Dent Today; 2010 Sep; 29(9):60-2, 64-6; quiz 68-9. PubMed ID: 20973418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis.
    Yuan H; Gupte R; Zelkha S; Amar S
    J Clin Periodontol; 2011 Nov; 38(11):1029-36. PubMed ID: 22092474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-methoxycarbonyl curcumin: a unique inhibitor of both inflammatory mediators and periodontal inflammation.
    Gu Y; Lee HM; Napolitano N; Clemens M; Zhang Y; Sorsa T; Zhang Y; Johnson F; Golub LM
    Mediators Inflamm; 2013; 2013():329740. PubMed ID: 24453415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo.
    Jimi E; Aoki K; Saito H; D'Acquisto F; May MJ; Nakamura I; Sudo T; Kojima T; Okamoto F; Fukushima H; Okabe K; Ohya K; Ghosh S
    Nat Med; 2004 Jun; 10(6):617-24. PubMed ID: 15156202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re: Non-surgical treatment of patients with periodontitis.
    Greenstein G; Ciancio S
    J Periodontol; 1997 Oct; 68(10):1023-8. PubMed ID: 9358372
    [No Abstract]   [Full Text] [Related]  

  • 32. Tumor necrosis factor-α enhances RANKL expression in gingival epithelial cells via protein kinase A signaling.
    Fujihara R; Usui M; Yamamoto G; Nishii K; Tsukamoto Y; Okamatsu Y; Sato T; Asou Y; Nakashima K; Yamamoto M
    J Periodontal Res; 2014 Aug; 49(4):508-17. PubMed ID: 24102429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisabolangelone isolated from Ostericum koreanum inhibits the production of inflammatory mediators by down-regulation of NF-kappaB and ERK MAP kinase activity in LPS-stimulated RAW264.7 cells.
    Jung HW; Mahesh R; Park JH; Boo YC; Park KM; Park YK
    Int Immunopharmacol; 2010 Feb; 10(2):155-62. PubMed ID: 19879381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappaB, iNOS, COX-2, TNF-alpha, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis.
    Umesalma S; Sudhandiran G
    Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):650-5. PubMed ID: 20406206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Host response modulation in the management of periodontal diseases.
    Salvi GE; Lang NP
    J Clin Periodontol; 2005; 32 Suppl 6():108-29. PubMed ID: 16128833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shifting paradigms in periodontal disease. Implications for prevention in the elderly.
    Vakkas TG
    N Y State Dent J; 1999 Nov; 65(9):24-8. PubMed ID: 10826023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation and bone loss in periodontal disease.
    Cochran DL
    J Periodontol; 2008 Aug; 79(8 Suppl):1569-76. PubMed ID: 18673012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bisphosphonate or RANK-L inhibitor for tumour-induced hypercalcaemia?
    Bech A; Essink G; de Boer H
    Neth J Med; 2012 Jun; 70(5):250-1. PubMed ID: 22744931
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumor necrosis factor and anti-tumor necrosis factor therapies.
    Keystone EC; Ware CF
    J Rheumatol Suppl; 2010 May; 85():27-39. PubMed ID: 20436163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Er-Miao-San, a traditional herbal formula containing Rhizoma Atractylodis and Cortex Phellodendri inhibits inflammatory mediators in LPS-stimulated RAW264.7 macrophages through inhibition of NF-κB pathway and MAPKs activation.
    Chen G; Li KK; Fung CH; Liu CL; Wong HL; Leung PC; Ko CH
    J Ethnopharmacol; 2014 Jul; 154(3):711-8. PubMed ID: 24815219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.